Dolby Laboratories, Inc.
DLB
$65.27
$1.081.68%
NYSE
| 06/26/2026 | 03/27/2026 | 12/26/2025 | 09/26/2025 | 06/27/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.35B | 1.36B | 1.34B | 1.35B | 1.35B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.35B | 1.36B | 1.34B | 1.35B | 1.35B |
| Cost of Revenue | 167.78M | 171.46M | 162.57M | 160.13M | 154.61M |
| Gross Profit | 1.19B | 1.19B | 1.18B | 1.19B | 1.19B |
| SG&A Expenses | 658.80M | 656.62M | 644.54M | 647.24M | 640.12M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.09B | 1.09B | 1.07B | 1.07B | 1.06B |
| Operating Income | 261.83M | 270.65M | 267.50M | 279.97M | 289.23M |
| Income Before Tax | 276.77M | 288.49M | 289.04M | 303.49M | 321.55M |
| Income Tax Expenses | 48.77M | 43.15M | 46.93M | 46.99M | 55.85M |
| Earnings from Continuing Operations | 228.00 | 245.33 | 242.10 | 256.49 | 265.70 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -1.83M | -1.69M | -1.58M | -1.47M | -1.45M |
| Net Income | 226.18M | 243.65M | 240.52M | 255.02M | 264.26M |
| EBIT | 261.83M | 270.65M | 267.50M | 279.97M | 289.23M |
| EBITDA | 354.67M | 362.82M | 357.11M | 367.79M | 376.41M |
| EPS Basic | 2.37 | 2.55 | 2.51 | 2.66 | 2.76 |
| Normalized Basic EPS | 1.94 | 1.99 | 2.00 | 2.06 | 2.13 |
| EPS Diluted | 2.35 | 2.53 | 2.48 | 2.63 | 2.72 |
| Normalized Diluted EPS | 1.93 | 1.97 | 1.98 | 2.03 | 2.10 |
| Average Basic Shares Outstanding | 380.56M | 382.21M | 383.32M | 383.47M | 383.24M |
| Average Diluted Shares Outstanding | 383.40M | 385.78M | 387.74M | 388.36M | 388.11M |
| Dividend Per Share | 1.44 | 1.41 | 1.38 | 1.35 | 1.32 |
| Payout Ratio | 59.36% | 54.13% | 53.80% | 49.64% | 46.78% |